Navigation Links
Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
Date:9/10/2007

Certain statements contained in this press release, including without limitation, statements containing the words "believes", "anticipates", "hopes", "intends", "expects", and other words of similar import, constitute "forward looking" statements within the meaning of the Private Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors, which may cause actual events to differ materially from expectations. Such factors include the following (1) technological, engineering, quality control or other circumstances which could delay the sale or shipment of the products; (2) economic, business, market and competitive conditions in the software industry and technological innovations which could affect the Company's business; (3) the Company's inability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others or prevent others from infringing on the proprietary rights of the Company; and (4) general economic and business conditions and the availability of sufficient financing.

CIC, its logo and The Power to Sign Online are registered trademarks. All other trademarks are properties of their respective owners.

Contact Information

CIC

Investor Relations Inquiries:

Chantal Eshghipour

650-802-7740

investorrelations@cic.com


'/>"/>
SOURCE Communication Intelligence Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology news :

1. Amgen introduces comprehensive financial assistance programs for cancer patients
2. Value of services performed by insects tops $57 billion in US
3. Ecosystem services and invasive species
4. NIH neuroscience microarray consortium launches high-throughput genotyping services
5. Restricting hospital-based services during SARS outbreak had modest impact
6. New Rotavirus vaccine joins routine infant immunization schedule
7. T-beta-RIII joins the fight against breast cancer
Post Your Comments:
*Name:
*Comment:
*Email: